Pawlitzki M - Search Results

1

Different Treatment Outcomes of Multiple Sclerosis Patients Receiving Ocrelizumab or Ofatumumab.

Meuth SG, Wolff S, Mück A, Willison A, Kleinschnitz K, Räuber S, Pawlitzki M, Konen FF, Skripuletz T, Grothe M, Ruck T, Huttner HB, Kleinschnitz C, Bopp T, Pul R, Cree BAC, Hartung HP, Möllenhoff K, Pfeuffer S. Meuth SG, et al. Among authors: pawlitzki m. Ann Neurol. 2024 Nov 25. doi: 10.1002/ana.27143. Online ahead of print. Ann Neurol. 2024. PMID: 39582359

2

Efficacy and safety of alemtuzumab versus fingolimod in RRMS after natalizumab cessation.

Pfeuffer S, Schmidt R, Straeten FA, Pul R, Kleinschnitz C, Wieshuber M, Lee DH, Linker RA, Doerck S, Straeten V, Windhagen S, Pawlitzki M, Aufenberg C, Lang M, Eienbroeker C, Tackenberg B, Limmroth V, Wildemann B, Haas J, Klotz L, Wiendl H, Ruck T, Meuth SG. Pfeuffer S, et al. Among authors: pawlitzki m. J Neurol. 2019 Jan;266(1):165-173. doi: 10.1007/s00415-018-9117-z. Epub 2018 Nov 16. J Neurol. 2019. PMID: 30446966

3

CSF macrophage migration inhibitory factor levels did not predict steroid treatment response after optic neuritis in patients with multiple sclerosis.

Pawlitzki M, Sweeney-Reed CM, Meuth SG, Reinhold D, Neumann J. Pawlitzki M, et al. PLoS One. 2018 Nov 26;13(11):e0207726. doi: 10.1371/journal.pone.0207726. eCollection 2018. PLoS One. 2018. PMID: 30475854 Free PMC article.

4

CSF Neurofilament Light Chain Levels in Primary Progressive MS: Signs of Axonal Neurodegeneration.

Pawlitzki M, Schreiber S, Bittner D, Kreipe J, Leypoldt F, Rupprecht K, Carare RO, Meuth SG, Vielhaber S, Körtvélyessy P. Pawlitzki M, et al. Front Neurol. 2018 Dec 14;9:1037. doi: 10.3389/fneur.2018.01037. eCollection 2018. Front Neurol. 2018. PMID: 30631300 Free PMC article.

5

CSF Neurofilament light chain level predicts axonal damage in cerebral vasculitis.

Pawlitzki M, Butryn M, Kirchner F, Färber J, Beuing O, Minnerup J, Meuth SG, Neumann J. Pawlitzki M, et al. Ann Clin Transl Neurol. 2019 Jun 3;6(6):1134-1137. doi: 10.1002/acn3.790. eCollection 2019 Jun. Ann Clin Transl Neurol. 2019. PMID: 31211179 Free PMC article.

6

Therapeutic Apheresis in Acute Relapsing Multiple Sclerosis: Current Evidence and Unmet Needs-A Systematic Review.

Rolfes L, Pfeuffer S, Ruck T, Melzer N, Pawlitzki M, Heming M, Brand M, Wiendl H, Meuth SG. Rolfes L, et al. Among authors: pawlitzki m. J Clin Med. 2019 Oct 4;8(10):1623. doi: 10.3390/jcm8101623. J Clin Med. 2019. PMID: 31590282 Free PMC article. Review.

7

Ineffective treatment of PML with pembrolizumab: Exhausted memory T-cell subsets as a clue?

Pawlitzki M, Schneider-Hohendorf T, Rolfes L, Meuth SG, Wiendl H, Schwab N, Grauer OM. Pawlitzki M, et al. Neurol Neuroimmunol Neuroinflamm. 2019 Oct 9;6(6):e627. doi: 10.1212/NXI.0000000000000627. Print 2019 Nov. Neurol Neuroimmunol Neuroinflamm. 2019. PMID: 31597692 Free PMC article. No abstract available.

8

Fulminant MS Reactivation Following Combined Fingolimod Cessation and Yellow Fever Vaccination.

Rolfes L, Pawlitzki M, Pfeuffer S, Thomas C, Schmidt-Chanasit J, Gross CC, Schulte-Mecklenbeck A, Wiendl H, Meuth SG, M Grauer O, Ruck T. Rolfes L, et al. Among authors: m grauer o, pawlitzki m. Int J Mol Sci. 2019 Nov 28;20(23):5985. doi: 10.3390/ijms20235985. Int J Mol Sci. 2019. PMID: 31795084 Free PMC article.

9

Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders.

Ringelstein M, Harmel J, Zimmermann H, Brandt AU, Paul F, Haarmann A, Buttmann M, Hümmert MW, Trebst C, Schroeder C, Ayzenberg I, Kleiter I, Hellwig K, Havla J, Kümpfel T, Jarius S, Wildemann B, Rommer P, Weber MS, Pellkofer H, Röpke L, Geis C, Retzlaff N, Zettl U, Deppe M, Klotz L, Young K, Stellmann JP, Kaste M, Kermer P, Marouf W, Lauda F, Tumani H, Graf J, Klistorner A, Hartung HP, Aktas O, Albrecht P; Neuromyelitis Optica Study Group (NEMOS). Ringelstein M, et al. Neurology. 2020 Jan 28;94(4):e407-e418. doi: 10.1212/WNL.0000000000008684. Epub 2019 Dec 3. Neurology. 2020. PMID: 31796527

10

Generation of a Model to Predict Differentiation and Migration of Lymphocyte Subsets under Homeostatic and CNS Autoinflammatory Conditions.

Gross CC, Pawlitzki M, Schulte-Mecklenbeck A, Rolfes L, Ruck T, Hundehege P, Wiendl H, Herty M, Meuth SG. Gross CC, et al. Among authors: pawlitzki m. Int J Mol Sci. 2020 Mar 17;21(6):2046. doi: 10.3390/ijms21062046. Int J Mol Sci. 2020. PMID: 32192056 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters